Total words: 5990 | 2-word phrases: 1553 | 3-word phrases: 1820 | 4-word phrases: 1912
Title | Try to keep the title under 60 characters (66 characters) DILANTIN® (extended phenytoin sodium capsules, USP) | Safety Info |
Description | Try to keep the meta description between 50 - 160 characters (86 characters) DILANTIN® (extended phenytoin sodium capsules, USP) Homepage. See risks and benefits. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (37 characters) MOVE FORWARD WITH BRAND-NAME DILANTIN |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | or | 184 | 26.10% | ||||||
2 | your | 182 | 25.82% | ||||||
3 | dilantin | 156 | 22.13% | ||||||
4 | of | 155 | 21.99% | ||||||
5 | and | 133 | 18.87% | ||||||
6 | you | 117 | 16.60% | ||||||
7 | to | 103 | 14.61% | ||||||
8 | a | 81 | 11.49% | ||||||
9 | the | 79 | 11.21% | ||||||
10 | can | 65 | 9.22% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.viatris.com/en | Whois | viatris.com |
2 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
3 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
4 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
5 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
6 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
7 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
8 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
9 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
10 | http://www.fda.gov/MedWatch | Whois | fda.gov |
11 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
12 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
13 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display | Whois | nih.gov |
14 | https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9&type=display#section-16 | Whois | nih.gov |
15 | https://www.viatris.com/en | Whois | viatris.com |
16 | https://www.viatris.com/en/terms-of-use | Whois | viatris.com |
17 | https://www.viatris.com/en/privacy-policy | Whois | viatris.com |
18 | https://www.viatris.com/en/supplemental-disclosure-for-california-residents | Whois | viatris.com |
19 | https://www.viatris.com/en/about-us/contact-us | Whois | viatris.com |
20 | https://www.viatris.com/en/About-Us | Whois | viatris.com |